Proteomics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
JAMA and Archives Journals
Certain biomarkers may have limited benefit for predicting cardiovascular events
July 13th, 2009
Use of several older and newer biomarkers appears to offer minimal added benefit in the prediction of cardiovascular events compared to conventional risk factors such as high cholesterol and high blood pressure, according to a study in the July 1 issue of JAMA. "Cost-effective cardiovascular prevention relies on the accurate identification of individuals at risk. However, a large proportion of individuals with cardiovascular events have 1 or fewer of the conventional risk factors, including smoking, diabetes, hypertension, or hyperlipidemia," the authors write. As a result, the use of recently identified biomarkers to supplement standard risk algorithms has attracted...
Source: Proteomics Weekly (2009-07-13)
|
